Literature DB >> 21849509

Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators.

Scott J Lusher1, Hans C A Raaijmakers, Diep Vu-Pham, Koen Dechering, Tsang Wai Lam, Angus R Brown, Niall M Hamilton, Olaf Nimz, Rolien Bosch, Ross McGuire, Arthur Oubrie, Jacob de Vlieg.   

Abstract

The progesterone receptor is able to bind to a large number and variety of ligands that elicit a broad range of transcriptional responses ranging from full agonism to full antagonism and numerous mixed profiles inbetween. We describe here two new progesterone receptor ligand binding domain x-ray structures bound to compounds from a structurally related but functionally divergent series, which show different binding modes corresponding to their agonistic or antagonistic nature. In addition, we present a third progesterone receptor ligand binding domain dimer bound to an agonist in monomer A and an antagonist in monomer B, which display binding modes in agreement with the earlier observation that agonists and antagonists from this series adopt different binding modes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21849509      PMCID: PMC3186393          DOI: 10.1074/jbc.M111.273029

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Progesterone antagonists and progesterone receptor modulators: an overview.

Authors:  Irving M Spitz
Journal:  Steroids       Date:  2003-11       Impact factor: 2.668

Review 2.  Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions.

Authors:  Raj Kumar; E Brad Thompson
Journal:  Mol Endocrinol       Date:  2003-01

3.  Atomic structure of progesterone complexed with its receptor.

Authors:  S P Williams; P B Sigler
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

Review 4.  Progesterone receptor modulators and progesterone antagonists in women's health.

Authors:  I M Spitz; K Chwalisz
Journal:  Steroids       Date:  2000 Oct-Nov       Impact factor: 2.668

5.  Human progesterone receptor A and B isoforms in CHO cells. I. Stable transfection of receptor and receptor-responsive reporter genes: transcription modulation by (anti)progestagens.

Authors:  R Dijkema; W G Schoonen; R Teuwen; E van der Struik; R J de Ries; B A van der Kar; W Olijve
Journal:  J Steroid Biochem Mol Biol       Date:  1998-02       Impact factor: 4.292

6.  Human progesterone receptor A and B isoforms in CHO cells. II. Comparison of binding, transactivation and ED50 values of several synthetic (anti)progestagens in vitro in CHO and MCF-7 cells and in vivo in rabbits and rats.

Authors:  W G Schoonen; R Dijkema; R J de Ries; J L Wagenaars; J W Joosten; M E de Gooyer; G H Deckers; H J Kloosterboer
Journal:  J Steroid Biochem Mol Biol       Date:  1998-02       Impact factor: 4.292

7.  The binding of progesterone, R-5020 and ORG-2058 to progesterone receptor.

Authors:  D D Keightley
Journal:  Eur J Cancer       Date:  1979-05       Impact factor: 9.162

Review 8.  Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy.

Authors:  Deborah DeManno; Walter Elger; Ramesh Garg; Ronald Lee; Birgitt Schneider; Holger Hess-Stumpp; Gerd Schubert; Kristof Chwalisz
Journal:  Steroids       Date:  2003-11       Impact factor: 2.668

Review 9.  Structure and function of the glucocorticoid receptor ligand binding domain.

Authors:  Randy K Bledsoe; Eugene L Stewart; Kenneth H Pearce
Journal:  Vitam Horm       Date:  2004       Impact factor: 3.421

10.  Progesterone receptor ligand binding pocket flexibility: crystal structures of the norethindrone and mometasone furoate complexes.

Authors:  Kevin P Madauss; Su-Jun Deng; Robert J H Austin; Millard H Lambert; Iain McLay; John Pritchard; Steven A Short; Eugene L Stewart; Ian J Uings; Shawn P Williams
Journal:  J Med Chem       Date:  2004-06-17       Impact factor: 7.446

View more
  10 in total

1.  X-ray structures of progesterone receptor ligand binding domain in its agonist state reveal differing mechanisms for mixed profiles of 11β-substituted steroids.

Authors:  Scott J Lusher; Hans C A Raaijmakers; Diep Vu-Pham; Bert Kazemier; Rolien Bosch; Ross McGuire; Rita Azevedo; Hans Hamersma; Koen Dechering; Arthur Oubrie; Marcel van Duin; Jacob de Vlieg
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

2.  Structural basis for negative cooperativity within agonist-bound TR:RXR heterodimers.

Authors:  Balananda-Dhurjati K Putcha; Edward Wright; Joseph S Brunzelle; Elias J Fernandez
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

3.  A new strategy for selective targeting of progesterone receptor with passive antagonists.

Authors:  Junaid A Khan; Abdellatif Tikad; Michel Fay; Abdallah Hamze; Jérôme Fagart; Nathalie Chabbert-Buffet; Geri Meduri; Larbi Amazit; Jean-Daniel Brion; Mouad Alami; Marc Lombès; Hugues Loosfelt; Marie-Edith Rafestin-Oblin
Journal:  Mol Endocrinol       Date:  2013-04-11

Review 4.  90 YEARS OF PROGESTERONE: Selective progesterone receptor modulators in gynaecological therapies.

Authors:  H O D Critchley; R R Chodankar
Journal:  J Mol Endocrinol       Date:  2020-07       Impact factor: 5.098

Review 5.  Elagolix in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.

Authors:  Mohamed Ali; Sara A R; Ayman Al Hendy
Journal:  Expert Rev Clin Pharmacol       Date:  2021-03-15       Impact factor: 5.045

6.  The glucocorticoid receptor dimer interface allosterically transmits sequence-specific DNA signals.

Authors:  Lisa C Watson; Kristopher M Kuchenbecker; Benjamin J Schiller; John D Gross; Miles A Pufall; Keith R Yamamoto
Journal:  Nat Struct Mol Biol       Date:  2013-06-02       Impact factor: 15.369

Review 7.  The therapeutic potential of RORγ modulators in the treatment of human disease.

Authors:  Mi Ra Chang; Devrishi Goswami; Becky A Mercer; Patrick R Griffin
Journal:  J Exp Pharmacol       Date:  2012-10-11

Review 8.  Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies.

Authors:  Andrea Wagenfeld; Philippa T K Saunders; Lucy Whitaker; Hilary O D Critchley
Journal:  Expert Opin Ther Targets       Date:  2016-05-14       Impact factor: 6.902

Review 9.  Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids.

Authors:  Mohamed Ali; Ayman Al-Hendy
Journal:  Biol Reprod       Date:  2017-09-01       Impact factor: 4.285

10.  EC313-a tissue selective SPRM reduces the growth and proliferation of uterine fibroids in a human uterine fibroid tissue xenograft model.

Authors:  Hareesh B Nair; Bindu Santhamma; Kalarickal V Dileep; Peter Binkley; Kirk Acosta; Kam Y J Zhang; Robert Schenken; Klaus Nickisch
Journal:  Sci Rep       Date:  2019-11-21       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.